New Era of Preventing End-Stage Kidney Disease Act

Bill 118 hr 6790, also known as the New Era of Preventing End-Stage Kidney Disease Act, is a piece of legislation introduced in the US Congress with the aim of improving the prevention and treatment of end-stage kidney disease. The bill seeks to address the growing prevalence of kidney disease in the United States and the significant impact it has on individuals and the healthcare system.

One of the key provisions of the bill is the establishment of a national strategy to prevent and treat kidney disease. This strategy would focus on increasing awareness of risk factors for kidney disease, promoting early detection and treatment, and improving access to care for individuals with kidney disease. The bill also calls for increased research funding for kidney disease, with a focus on developing new treatments and improving outcomes for patients.

Additionally, the New Era of Preventing End-Stage Kidney Disease Act includes provisions to improve coordination of care for individuals with kidney disease, including the development of care coordination programs and the expansion of telehealth services for kidney disease patients. The bill also aims to increase access to kidney transplants and improve the quality of care for individuals on dialysis. Overall, the New Era of Preventing End-Stage Kidney Disease Act is a comprehensive piece of legislation that seeks to address the growing burden of kidney disease in the United States. By focusing on prevention, early detection, and improved treatment options, the bill aims to improve outcomes for individuals with kidney disease and reduce the overall impact of the disease on the healthcare system.